A recent paper examining daptomycin susceptible S. aureus strains found an overall decrease in MIC values after storage when tested by Etest [36]. This is in contrast to our study in which all but one strain Selinexor datasheet was stable on repeat testing over two years later. These differences may be due to the testing method (Etest vs. BMD) or the MIC stability of daptomycin susceptible versus daptomycin non-susceptible

S. aureus. While it appears from our work that the majority of all daptomycin non-susceptible clinical strains are indeed stable, further research in this area is needed to confirm these findings, as most studies to date have not examined the stability of DNS S. aureus clinical isolates. In this study, we found variation in the susceptibility to daptomycin when the isolates were examined by population analysis with some isolates displaying prominent left or right shifts. Previous work has found the occurrence of daptomycin heteroresistance in both daptomycin susceptible and DNS S. aureus strains. Examination of the previously mentioned clinical isogenic pair, SA-675 and SA-684, by daptomycin population analysis revealed a heterogeneous profile [15]. Examination of a series of S. aureus isolates, ranging from daptomycin susceptible to DNS, recovered from a patient receiving high-dose daptomycin therapy by daptomycin population analysis revealed the presence of daptomycin

heteroresistance on visual inspection both before and after the development of DNS [37]. In our study we also found a shift

in the profile from the isolates recovered from the in vitro model after 96 h of exposure Selleckchem Dactolisib Anidulafungin (LY303366) to daptomycin. This is consistent with the shift seen in clinical pairs analyzed after in vivo exposure to daptomycin [15, 37]. Examination of the impact of a DNS S. aureus daptomycin population profile on the activity of daptomycin in the in vitro PK/PD model of SEVs revealed unique killing patterns. The two isolates with left-shift profiles displayed one initial decrease in colony counts followed by a gradual regrowth, while the two right-shift profile isolates displayed multiple cycles of killing and regrowth. The extent of the antimicrobial activity may also be explained by the daptomycin PAPs. Compared to R6003, R6219 exhibited a greater decrease in colony counts when exposed to both daptomycin 6 and 10 mg/kg in the in vitro PK/PD SEV model despite having the same/higher daptomycin MIC value. These increases in susceptibility to daptomycin may be explained by the smaller AUC of the daptomycin PAP of R6219 (AUC 20.68) compared to R6003 (AUC 22.14). No correlation was observed, however, between the daptomycin PAP/AUC and the colony counts at 72–96 h in the in vitro PK/PD model. Examination of our strains for mutations in the mprF gene revealed common mutations previously described including the E692Q, P314L, L826F and S337L.